NCT04844151 Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical Assessment
| NCT ID | NCT04844151 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Myocarditis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,400 participants |
| Start Date | 2022-01-23 |
| Primary Completion | 2041-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,400 participants in total. It began in 2022-01-23 with a primary completion date of 2041-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The AMPHIBIA study is an observational ambispective and prospective cohort that aim to describe the histologic, immunologic, biological, imaging, genetic and clinical characteristics of the patients hospitalized for an acute myocarditis and to evaluate their association with prognosis.
Eligibility Criteria
Inclusion Criteria: * Acute myocarditis confirmed by cardiac magnetic resonance according to Lake Louise modified criteria or by endomyocardial biopsy according to histologic, immunologic and immunohistochemic criteria. * affiliation to the French Health Care System "Sécurité sociale" Exclusion Criteria: * Severe valvulopathy * Complex congenital cardiopathy * Previous heart transplant * Known significative coronary disease
Contact & Investigator
Giles MONTALESCOT, MD, PhD
STUDY DIRECTOR
ACTION Study Group - Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT04844151 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, studying Myocarditis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04844151 currently recruiting?
Yes, NCT04844151 is actively recruiting participants. Contact the research team at mathieu.kerneis@aphp.fr for enrollment information.
Where is the NCT04844151 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT04844151 clinical trial?
NCT04844151 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Giles MONTALESCOT, MD, PhD at ACTION Study Group - Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 1,400 participants.